Canada's Decision To Make Public More Clinical Trial Data Puts Pressure On FDA
Posted on AllSides October 11th, 2019
From The Left
Last March, Canada's department of health changed the way it handles the huge amount of data that companies submit when seeking approval for a new drug, biological treatment, or medical device — or a new use for an existing one. For the first time, Health Canada is making large chunks of this information publicly available after it approves or rejects applications.